Bristol-Myers Squibb reports positive results from CheckMate -214 phase 3 study of Opdivo
Bristol-Myers Squibb Company announced topline results from the CheckMate -214 trial investigating Opdivo (nivolumab) in combination with Yervoy (ipilimumab) versus sunitinib in intermediate and...
A New Drug Research And Development Cooperation Reached By Chengdu Pilot And Aduro
Chengdu Pioneer Drug Development Co., Ltd. announced a multi-year, long-term, new drug research and development collaboration with Aduro Biotech to achieve a new small...
CARsgen Launches First-in-Class Anti-Claudin18.2 CAR-T Clinical Trial
CARsgen Therapeutics (CARsgen), a global leader in developing chimeric antigen receptor T-cell (CAR-T cell) therapies for solid tumors announced its first-in-class anti-Claudin18.2-CAR-T cell therapy...
Motif Bio’s second Phase 3 clinical trial in ABSSSI finishes patient treatment phase
Motif Bio plc ,the clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced that the last patient has completed the treatment phase in...
First FDA-Approved Treatment for ALS in 22 Years Now Available in U.S
Mitsubishi Tanabe Pharma America, Inc. announced RADICAVA ™ (edaravone), an intravenous therapy indicated for all adult patients diagnosed with amyotrophic lateral sclerosis (ALS), also known as...
FDA Approval Of CaroSpir Announced By CMP Pharma , Inc.
CMP Pharma announced that the US FDA has granted final approval of the company’s NDA for CaroSpir® (Spironolactone Oral Suspension, 25 mg/5mL), the first...
Takeda and Molecular templates announce research and collaboration to develop next-generation oncology therapies
Takeda Pharma and Molecular Templates, Inc. announced a collaboration agreement for oncology drug discovery programs. The collaboration will apply Molecular Templates’ETB technology platform to...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...